Company: BDRX
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001214659-25-006756
Chunk: 46

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-01
Form: DRS
Chunk 46
---
 (without
regard to any limitation on exercise set forth therein), the number of Units including a Depositary Share we are offering will be decreased
on a one-for-one basis. Because one Series L Warrant is being sold together in this offering with each Depositary Share or, in the alternative,
each Pre-Funded Warrant to purchase one Depositary Share, the number of Series L Warrants sold in this offering will not change as a result
of a change in the mix of the Depositary Shares and Pre-Funded Warrants sold.

The
Units have no standalone rights and will not be certificated or issued as standalone securities. The Depositary Shares or Pre-Funded Warrants
and Series L Warrants comprising the Units are immediately separable and will be issued separately in this offering.

American Depositary Shares

Please see the sections titled
“Description of American Depositary Shares” and “Description of Share Capital” in this prospectus
for a description of the material terms of our American Depositary Shares and the underlying Ordinary Shares and our Articles of Association.

Pre-Funded Warrants and Series L Warrants

The following summary of certain terms and provisions of the Pre-Funded Warrants and Series L Warrants offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the form of Pre-Funded Warrant and the form of Series L Warrant, which will be filed as exhibits to the registration statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions set forth in the form of Series L Warrant and form of Pre-Funded Warrant.

Duration, Exercise Price and Form. The exercise price for the Pre-Funded Warrants is $0.0001 per Depositary Share The Pre-Funded Warrants
are exercisable at any time after their original issuance until they are exercised in full. Each Series L Warrant will have an initial
exercise price of $ per share, which equals % of the public offering price per Unit. The Series L Warrants will
be immediately exercisable upon issuance and will expire two and one-half (2.5) years after the original issuance date. The exercise price
and the number of Depositary Shares issuable upon exercise are subject to adjustment in the event of share dividends, share splits, reorganizations,
or similar events affecting our Ordinary Shares and the exercise price. In addition, at 4:01 p.m. Eastern time on the First Reset Date,
the exercise price of